CMS Plan To Reduce Antipsychotic Use In Nursing Homes By 15% Plays Up Non-Regulatory Approaches
This article was originally published in The Pink Sheet Daily
Efforts will include provider training, posting of nursing home prescribing rates on Medicare’s Nursing Home Compare website.
You may also be interested in...
CMS estimates that removing antidepressants, antipsychotics and immunosuppressants from “protected class” status in Medicare Part D could save $720 million between 2016 and 2019.
A program launched in 2012, the National Partnership to Improve Dementia Care, is on its way to meeting goals of lowering the use of antipsychotic drugs in nursing homes by 15%, with 11 states already hitting that target.
CMS will not implement an earlier regulatory proposal requiring that consultant pharmacists maintain independence from long-term care facilities or drug firms at this point.